Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol vs. Narcotics for Post-Op Pain in Shoulder Arthroscopy
NCT05240755Phase 1Completed
- Sponsor
- Foundation for Orthopaedic Research and Education
- Start
- Jul 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cannabidiol in postoperative pain (3 arms), sponsored by Foundation for Orthopaedic Research and Education. Primary endpoint: Post-operative pain at 30 days. Started Jul 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05240755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05240755.